Cross-source identity
National Provider Identifier 1265782668 as it appears in every federal dataset Fonteum holds. Each row is a distinct public source; the chip carries the source and the snapshot date behind that field — the record-level form of the source-provenanced graph.
| Federal source | Key | What it provides | Provenance |
|---|
| CMS NPPES | NPI 1265782668 | Registry identity — psychiatrist, taxonomy 2084P0800X | Source:CMS NPPESSnapshot 2026-05-06 |
| CMS Open Payments | NPI 1265782668 | 7 industry-payment records, 2024 | Source:CMS Open PaymentsSnapshot PY2024 |
| CMS Medicare Part D | NPI 1265782668 | 3 drugs prescribed, 2024 | Source:CMS Part DSnapshot DY2024 |
Industry payments
Payments and transfers of value this clinician received from drug and device manufacturers, disclosed under the Physician Payments Sunshine Act. A payment is a disclosure, not a judgment.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $141 | 7 |
| Manufacturer | Amount | Records |
|---|---|---|
| Abbvie Inc. | $54 | 2 |
| Indivior Inc. | $35 | 2 |
| Teva Pharmaceuticals Usa, Inc. | $35 |
Prescribing
Prescriptions written under Medicare Part D, aggregated by drug across the program. Totals reflect claims paid, not patients treated.
| Drug | Claims | Drug cost |
|---|---|---|
| Gabapentin | 14 | $158 |
| Hydroxyzine Pamoate | 12 | $126 |
| Trazodone Hcl | 21 | $117 |
Quality
CMS Quality Payment Program Merit-based Incentive Payment System (MIPS) final score, where this clinician participated. Absence of a score is not a quality signal — many clinicians report through a group or are exempt.
Enrollment & sanctions
Screening aid — re-confirm any match against the issuing list before acting. A clean result means no record was found in the federal OIG LEIE or the state Medicaid lists Fonteum currently holds (NY, OH, GA), not a guarantee that none exists elsewhere. Not a legal or credentialing certification.
| 2 |
| Otsuka America Pharmaceutical, Inc. | $18 | 1 |